19-NOREPIANDROSTERONE

[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@@]4([H])C[C@@H](O)CC[C@]34[H]

InChIKey=UOUIARGWRPHDBX-LRMMUPRLSA-N

InChI=1S/C18H28O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h11-16,19H,2-10H2,1H3/t11-,12-,13-,14+,15+,16-,18-/m0/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	7 / 7
E/Z Centers	0
Optical Activity	UNSPECIFIED

Substance Class	Chemical Created by `admin` on `Sat Dec 16 10:37:13 GMT 2023` Edited by `admin` on `Sat Dec 16 10:37:13 GMT 2023`
Record UNII	XRW43NN001
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

19-NOREPIANDROSTERONE

Common Name

English

5.ALPHA.-ESTRAN-17-ONE, 3.BETA.-HYDROXY-

Systematic Name

English

ESTRAN-17-ONE, 3-HYDROXY-, (3.BETA.,5.ALPHA.)-

Systematic Name

English

(3.BETA.,5.ALPHA.)-3-HYDROXYESTRAN-17-ONE

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID101017045

Created by admin on Sat Dec 16 10:37:13 GMT 2023 , Edited by admin on Sat Dec 16 10:37:13 GMT 2023

PRIMARY

FDA UNII

XRW43NN001

Created by admin on Sat Dec 16 10:37:13 GMT 2023 , Edited by admin on Sat Dec 16 10:37:13 GMT 2023

PRIMARY

CAS

10002-93-4

Created by admin on Sat Dec 16 10:37:13 GMT 2023 , Edited by admin on Sat Dec 16 10:37:13 GMT 2023

PRIMARY

PUBCHEM

14009229

Created by admin on Sat Dec 16 10:37:13 GMT 2023 , Edited by admin on Sat Dec 16 10:37:13 GMT 2023

PRIMARY